CHEBI:167686 - brivanib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name brivanib
ChEBI ID CHEBI:167686
Definition A secondary alcohol resulting from the hydrolysis of the carboxylic ester group of brivanib alaninate. It is a dual VEGFR-2/FGFR-1 kinase inhibitor whose alanine prodrug, brivanib alaninate is currently under development as an oral agent for the treatment of cancer.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C19H19FN4O3
Net Charge 0
Average Mass 370.384
Monoisotopic Mass 370.14412
InChI InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1
InChIKey WCWUXEGQKLTGDX-LLVKDONJSA-N
SMILES C[C@@H](O)COC1=CN2N=CN=C(OC3=C(F)C4=C(NC(C)=C4)C=C3)C2=C1C
Roles Classification
Biological Role(s): EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
fibroblast growth factor receptor antagonist
An antagonist at the fibroblast growth factor receptor.
drug metabolite

Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing brivanib (CHEBI:167686) has role angiogenesis inhibitor (CHEBI:48422)
brivanib (CHEBI:167686) has role antineoplastic agent (CHEBI:35610)
brivanib (CHEBI:167686) has role apoptosis inducer (CHEBI:68495)
brivanib (CHEBI:167686) has role drug metabolite (CHEBI:49103)
brivanib (CHEBI:167686) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434)
brivanib (CHEBI:167686) has role fibroblast growth factor receptor antagonist (CHEBI:63457)
brivanib (CHEBI:167686) is a aromatic ether (CHEBI:35618)
brivanib (CHEBI:167686) is a diether (CHEBI:46786)
brivanib (CHEBI:167686) is a fluoroindole (CHEBI:131960)
brivanib (CHEBI:167686) is a pyrrolotriazine (CHEBI:88341)
brivanib (CHEBI:167686) is a secondary alcohol (CHEBI:35681)
Incoming brivanib alaninate (CHEBI:167656) has functional parent brivanib (CHEBI:167686)
IUPAC Name
(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol
Synonyms Sources
(R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol ChEBI
BMS 540215 ChemIDplus
BMS-540215 ChemIDplus
BMS540215 ChemIDplus
Manual Xrefs Databases
9409099 ChemSpider
D09589 KEGG DRUG
DB11958 DrugBank
WO2011044019 Patent
View more database links
Registry Number Type Source
649735-46-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
16570908 PubMed citation Europe PMC
18288793 PubMed citation Europe PMC
19396600 PubMed citation Europe PMC
20671097 PubMed citation Europe PMC
21289073 PubMed citation Europe PMC
24780101 PubMed citation Europe PMC
30595557 PubMed citation Europe PMC
31270802 PubMed citation Europe PMC
31522033 PubMed citation Europe PMC
31633365 PubMed citation Europe PMC
Last Modified
16 March 2021